NRSPP Upcoming Webinars
Today, 2:00pm AEDT
Laing O’Rourke:
Leadership At The Top Drives Safety For All
Join us for this FREE National Road Safety Partnership Program (NRSPP) webinar.
Date: March 25, 2:00pm AEDT
Presenter: Daniel Kelly
528,000 tonnes of soil? 84,000 tonnes of concrete? 7200 tonnes of steel?
Imagine being responsible for moving all that through the heart of Sydney! That’s a job for Laing O’Rourke, and it’s up to our presenter Daniel Kelly to do it safely.
When constructing major multi-billion-dollar transport infrastructure projects, the greatest risk comes from transport logistics that often require heavy vehicle movements through the heart of cities. Laing O’Rourke is part of Australia’s largest infrastructure project, Sydney Metro, and responsible for the Central Station build. Their approach is highlighted as best practice in how they have applied the safety standards required by Sydney Metro.
This webinar will explore how Laing O’Rourke’s on-the-ground compliance and logistics management approach benefits those working on the project and safely interactions with the public.
April
Medicinal Cannabis and Mobile Workers:
What do I need to know?
Join us for this FREE National Road Safety Partnership Program (NRSPP) webinar.
Date: April 22, 11:00am AEST
Presenters: Associate Professor David Allen, Andrew Leibie
The use of cannabis for medicinal reasons is growing in Australia. Its use is complicated, often medically controversial and has significant ramifications for workplaces, especially mobile workers.
The differences between medicinal and recreational cannabis will be discussed. The potential impact on workplace activities including driving will be reviewed and how these can be managed will be highlighted.
Prescription Drugs and the Mobile Workforce: How can we assess and manage the risk?
Join us for this FREE National Road Safety Partnership Program (NRSPP) webinar.
Date: April 29, 11:00am AEST
Presenters: Associate Professor David Allen, Andrew Leibie
While many fitness for work programs include some form of drug testing, often the focus is on the presence of illicit drugs, due to their known effects on driving performance. However the effects of prescription drugs is often overlooked, despite potentially having similar risk profiles.
Although a complex area, given the interaction of individual privacy restrictions, fatigue management and other considerations, this presentation will present some metrics for assessing risk as well as tools for risk reduction in the workplace.
